uniQure (QURE) Change in Accured Expenses (2016 - 2026)

uniQure's (QURE) quarterly Change in Accured Expenses came in at $3.9 million in Q1 2026, up 423.49% year-on-year from $744624.3 in Q1 2025, and up 126.25% quarter-over-quarter from -$14.8 million in Q4 2025.

uniQure (QURE) Change in Accured Expenses (2016 - 2026) Analysis & Trends

uniQure's Change in Accured Expenses history runs 11 years deep, the most recent figure standing at $3.9 million for Q1 2026.

  • On a quarterly basis, Change in Accured Expenses rose 423.49% year-over-year to $3.9 million in Q1 2026; TTM through Mar 2026 was $9.6 million, a 656.48% increase from a year earlier, with the FY2025 full-year figure at $4.5 million, up 179.3% from the prior year.
  • Change in Accured Expenses climbed to $3.9 million in Q1 2026 per QURE's latest filing, from -$14.8 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $22.6 million in Q3 2025 and bottomed at -$14.8 million in Q4 2025.
  • The 5-year median for Change in Accured Expenses is -$248000.0 (2022), against an average of $46294.1.
  • Across the five-year window, Change in Accured Expenses tumbled 682.77% in 2024 and jumped 537.32% in 2025, its largest moves.
  • Year by year, Change in Accured Expenses stood at -$248000.0 in 2022, then jumped by 373.79% to $679000.0 in 2023, then tumbled by 682.77% to -$4.0 million in 2024, then plunged by 275.21% to -$14.8 million in 2025, then jumped by 126.25% to $3.9 million in 2026.
  • Per Business Quant, the three latest QURE Change in Accured Expenses figures stand at $3.9 million (Q1 2026), -$14.8 million (Q4 2025), and $22.6 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 1.13 Mn
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 931,000.00
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -16.82 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 23.10 Mn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 107.70 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - -16.74 Mn
10 uniQure 2.41 Bn 2.41 Bn 3.34 Mn 3.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.90 Mn
Mar 31, 2026 3.90 Mn
Dec 31, 2025 -14.85 Mn
Dec 31, 2025 -14.85 Mn
Sep 30, 2025 22.59 Mn
Sep 30, 2025 22.59 Mn
Jun 30, 2025 -2.07 Mn
Jun 30, 2025 -2.07 Mn
Mar 31, 2025 -1.21 Mn
Mar 31, 2025 -1.21 Mn
Dec 31, 2024 -3.96 Mn
Dec 31, 2024 -3.96 Mn
Sep 30, 2024 3.55 Mn
Sep 30, 2024 3.55 Mn
Jun 30, 2024 2.88 Mn
Jun 30, 2024 2.88 Mn
Mar 31, 2024 -8.11 Mn
Mar 31, 2024 -8.11 Mn
Dec 31, 2023 679,000.00
Dec 31, 2023 679,000.00